Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-02
DOI
10.1038/s41598-020-59600-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SWISS-MODEL: homology modelling of protein structures and complexes
- (2018) Andrew Waterhouse et al. NUCLEIC ACIDS RESEARCH
- Identifying vancomycin as an effective antibiotic for killing Borrelia burgdorferi
- (2018) Xiaoqian Wu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease
- (2018) Venkata Raveendra Pothineni et al. Drug Design Development and Therapy
- Crystal structures of penicillin-binding protein 3 in complexes with azlocillin and cefoperazone in both acylated and deacylated forms
- (2016) Jingshan Ren et al. FEBS LETTERS
- Screening of NCI-DTP library to identify new drug candidates for Borrelia burgdorferi
- (2016) Venkata Raveendra Pothineni et al. JOURNAL OF ANTIBIOTICS
- Cimetidine as a novel adjunctive treatment for early stage Lyme disease
- (2016) Justin Shemenski MEDICAL HYPOTHESES
- Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening
- (2016) Venkata Pothineni et al. Drug Design Development and Therapy
- Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime
- (2016) Jie Feng et al. Frontiers in Microbiology
- Persister Development by Borrelia burgdorferi PopulationsIn Vitro
- (2015) John R. Caskey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells
- (2015) Bijaya Sharma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Macrophage Polarization during Murine Lyme Borreliosis
- (2015) Carrie E. Lasky et al. INFECTION AND IMMUNITY
- Lyme disease: A rigorous review of diagnostic criteria and treatment
- (2015) Andrea T. Borchers et al. JOURNAL OF AUTOIMMUNITY
- Persister mechanisms in Borrelia burgdorferi: implications for improved intervention
- (2015) Jie Feng et al. Emerging Microbes & Infections
- Drug Combinations against Borrelia burgdorferi Persisters In Vitro: Eradication Achieved by Using Daptomycin, Cefoperazone and Doxycycline
- (2015) Jie Feng et al. PLoS One
- β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus USA300 Is Increased by Inactivation of the ClpXP Protease
- (2014) Kristoffer T. Bæk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Editorial Commentary: Xenodiagnosis for Posttreatment Lyme Disease Syndrome: Resolving the Conundrum or Adding to It?
- (2014) L. K. Bockenstedt et al. CLINICAL INFECTIOUS DISEASES
- Xenodiagnosis to Detect Borrelia burgdorferi Infection: A First-in-Human Study
- (2014) Adriana Marques et al. CLINICAL INFECTIOUS DISEASES
- Tick-borne infections of animals and humans: a common ground
- (2014) Gad Baneth INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Resurgence of Persisting Non-Cultivable Borrelia burgdorferi following Antibiotic Treatment in Mice
- (2014) Emir Hodzic et al. PLoS One
- Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
- (2014) Jie Feng et al. Emerging Microbes & Infections
- Treatment Trials for Post-Lyme Disease Symptoms Revisited
- (2013) Mark S. Klempner et al. AMERICAN JOURNAL OF MEDICINE
- Molecular Mechanism of Bacterial Persistence by HipA
- (2013) Elsa Germain et al. MOLECULAR CELL
- Pharmacological Inhibition of the ClpXP Protease Increases Bacterial Susceptibility to Host Cathelicidin Antimicrobial Peptides and Cell Envelope-Active Antibiotics
- (2012) Shauna M. McGillivray et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dynamic and static components power unfolding in topologically closed rings of a AAA+ proteolytic machine
- (2012) Steven E Glynn et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection
- (2012) Monica E. Embers et al. PLoS One
- Characterization of Biofilm Formation by Borrelia burgdorferi In Vitro
- (2012) Eva Sapi et al. PLoS One
- Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
- (2010) Tobias Dörr et al. PLOS BIOLOGY
- Antibiotic Treatment of Animals Infected with Borrelia burgdorferi
- (2009) G. P. Wormser et al. CLINICAL MICROBIOLOGY REVIEWS
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
- (2009) Oleg Trott et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
- (2009) J.-E. Hugonnet et al. SCIENCE
- Persistence of Borrelia burgdorferi following Antibiotic Treatment in Mice
- (2008) E. Hodzic et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactams as Selective Chemical Probes for the in Vivo Labeling of Bacterial Enzymes Involved in Cell Wall Biosynthesis, Antibiotic Resistance, and Virulence
- (2008) Isabell Staub et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started